Berlin, Germany

Zoltán Konthur


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Zoltán Konthur: Innovator in Biomarker Research

Introduction

Zoltán Konthur is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biomarker research, particularly in the context of anti-tumor necrosis factor alpha (TNF) treatments. With a total of four patents to his name, Konthur's work has the potential to impact the diagnosis and treatment of various conditions.

Latest Patents

One of Konthur's latest patents focuses on a method for diagnosing individuals who are to be subjected to or are currently undergoing anti-TNF treatment. This invention involves the detection of immunoglobulins against specific biomarker proteins in bodily fluids or excrement. Based on this detection, individuals can be classified as either NON-responders or responders to the treatment. Additionally, the patent includes diagnostic kits that utilize these biomarker proteins to assess responsiveness to anti-TNF treatments.

Career Highlights

Throughout his career, Zoltán Konthur has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Charité – Universitätsmedizin Berlin. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Konthur's notable coworkers include Hans Lehrach and Karl Skriner. Their collaborative efforts have further advanced the research and development of innovative diagnostic methods.

Conclusion

Zoltán Konthur's work in biomarker research exemplifies the importance of innovation in medical diagnostics. His contributions have the potential to enhance treatment outcomes for patients undergoing anti-TNF therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…